Halozyme Therapeutics HALO
NASDAQ HALO
$109.86 +2.92 (+2.73%)
At close: Oct 2, 2026 · 4:00 PM EDT

Halozyme Therapeutics (HALO) Cash & Current Investments (2010 - 2026)

Updated

Halozyme Therapeutics (HALO) reported Cash & Current Investments of $231 million for Q2 2026, down 57.9% from $548.18 million a year earlier and down 27.5% from the prior quarter.

Analysis

Halozyme Therapeutics (HALO) Cash & Current Investments (2010 - 2026) Analysis & Trends

At the end of FY2025, Halozyme Therapeutics posted Cash & Current Investments of $142.82 million, down 76.0% from FY2024.

  • Cash & Current Investments has a five-year compound annual growth rate of -17.2% (FY2020 to FY2025).
  • By year, Cash & Current Investments came in at $596.07 million in FY2024 (+77.4%), $336 million in FY2023 (-7.4%), $362.79 million in FY2022 (-51.0%) and $740.92 million in FY2021 (+101.3%).
  • Five-year quarterly Cash & Current Investments spans a low of $142.82 million in Q4 2025 and a high of $815.92 million in Q3 2021.
  • Year over year, Cash & Current Investments has now declined in each of the last three quarters, with an average decline of 0.7% over the last eight quarters.
  • The high point for year-over-year Cash & Current Investments in five years was Q3 2021 (growth of 135.3%); the low point was Q4 2025 (a decline of 76.0%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $318.62 million (Q1 2026), $142.82 million (Q4 2025) and $701.96 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Halozyme Therapeutics 12.53 Bn 11.13 Bn 401.83 Mn 231.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 231.00 Mn
Mar 31, 2026 318.62 Mn
Dec 31, 2025 142.82 Mn
Sep 30, 2025 701.96 Mn
Jun 30, 2025 548.18 Mn
Mar 31, 2025 747.92 Mn
Dec 31, 2024 596.07 Mn
Sep 30, 2024 666.31 Mn
Jun 30, 2024 529.03 Mn
Mar 31, 2024 463.45 Mn
Dec 31, 2023 336.00 Mn
Sep 30, 2023 483.28 Mn
Jun 30, 2023 348.28 Mn
Mar 31, 2023 275.61 Mn
Dec 31, 2022 362.79 Mn
Sep 30, 2022 265.58 Mn
Jun 30, 2022 209.36 Mn
Mar 31, 2022 786.14 Mn
Dec 31, 2021 740.92 Mn
Sep 30, 2021 815.92 Mn
API Access

Halozyme Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=HALO&period=max&api_key=YOUR_API_KEY